HUBRO THERAPEUTICS AS
Organization
- CEO
- ØK
- Chairman of the board
- ØK
- Years since formation
- 7 years
- since Dec 5, 2018
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 4,135,877
- 1 share class
- Total number of shareholders
- 43
- 38 companies, 5 persons
Financials
- Annual total result 2022
- -31,551,681
- NOK
- Total equity 2022
- 36,467,975
- NOK
Last update: Sep 9, 2025
Management
Management / administration
Name | Role | Shares |
---|---|---|
ØK | Managing Director/CEO | - |
Board
Name | Role | Shares |
---|---|---|
Board Member | 5.01 % indirectly | |
ØK | Chairman | - |
AP | Board Member | - |
BG | Board Member | - |
Others
Name | Role | Shares |
---|---|---|
Auditor | - | |
Accountant | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
KM | - | 12.37 % indirectly |
JA | - | 8.14 % indirectly |
Board Member | 5.01 % indirectly | |
TA 1967 | - | 4.99 % indirectly |
PC 1962 | - | 3.26 % indirectly |
SM | - | 1.25 % indirectly |
SO 2003 | - | 1.04 % indirectly |
EO 2005 | - | 1.04 % indirectly |
Last update: Mar 2, 2024
Ownership
Company shareholders
Name | Share class | Total number of shares | Share |
---|---|---|---|
NO0012442260 | 908,953 | 21.98 % | |
NO0012442260 | 570,514 | 13.79 % | |
NO0012442260 | 414,246 | 10.02 % | |
NO0012442260 | 336,831 | 8.14 % | |
NO0012442260 | 310,237 | 7.5 % | |
NO0012442260 | 304,406 | 7.36 % | |
NO0012442260 | 245,417 | 5.93 % | |
NO0012442260 | 186,395 | 4.51 % | |
NO0012442260 | 143,403 | 3.47 % | |
NO0012442260 | 134,898 | 3.26 % | |
NO0012442260 | 100,000 | 2.42 % | |
NO0012442260 | 53,461 | 1.29 % | |
NO0012442260 | 51,706 | 1.25 % | |
NO0012442260 | 41,291 | 1 % | |
NO0012442260 | 40,552 | 0.98 % | |
NO0012442260 | 39,991 | 0.97 % | |
NO0012442260 | 30,158 | 0.73 % | |
NO0012442260 | 28,680 | 0.69 % | |
NO0012442260 | 25,484 | 0.62 % | |
NO0012442260 | 21,956 | 0.53 % | |
NO0012442260 | 18,375 | 0.44 % | |
NO0012442260 | 17,670 | 0.43 % | |
NO0012442260 | 17,596 | 0.43 % | |
NO0012442260 | 13,638 | 0.33 % | |
AR | NO0012442260 | 10,000 | 0.24 % |
NO0012442260 | 10,000 | 0.24 % | |
NO0012442260 | 7,682 | 0.19 % | |
NO0012442260 | 7,422 | 0.18 % | |
NO0012442260 | 5,022 | 0.12 % | |
NO0012442260 | 4,663 | 0.11 % | |
NO0012442260 | 4,663 | 0.11 % | |
NO0012442260 | 4,425 | 0.11 % | |
NO0012442260 | 4,383 | 0.11 % | |
NO0012442260 | 3,730 | 0.09 % | |
NO0012442260 | 3,535 | 0.09 % | |
NO0012442260 | 3,151 | 0.08 % | |
NO0012442260 | 3,125 | 0.08 % | |
NO0012442260 | 2,500 | 0.06 % | |
NO0012442260 | 2,303 | 0.06 % | |
AS 1972 | NO0012442260 | 1,875 | 0.05 % |
NO0012442260 | 772 | 0.02 % | |
NO0012442260 | 384 | < 0.01 % | |
NO0012442260 | 384 | < 0.01 % |
Last update: May 24, 2024
Financials
in NOK
Summary
Year | 2022 | 2021 |
---|---|---|
Total operating income | 0 | 53,550 |
Annual Total Result | -31,551,681 | -7,536,854 |
Total assets | 83,591,652 | 71,599,935 |
Total liabilities | 47,123,677 | 3,580,279 |
Total equity | 36,467,975 | 68,019,656 |
P&L
Year | 2022 | 2021 |
---|---|---|
Total operating income | 0 | 53,550 |
Total operating costs | 31,712,751 | 7,704,941 |
Operating result | -31,712,751 | -7,651,391 |
Financial income/costs | 161,070 | 114,537 |
Profit before tax | -31,551,681 | -7,536,854 |
Total tax & extraordinary income/cost | 0 | 0 |
Annual Total Result | -31,551,681 | -7,536,854 |
Balance overview
Year | 2022 | 2021 |
---|---|---|
Total fixed assets | 10,070,146 | 0 |
Total current assets | 73,521,506 | 71,599,935 |
Total assets | 83,591,652 | 71,599,935 |
Short term debt | 11,698,677 | 3,580,279 |
Long term debt | 35,425,000 | 0 |
Total liabilities | 47,123,677 | 3,580,279 |
Contributed capital | 36,467,975 | 68,019,656 |
Retained earnings | 0 | 0 |
Total equity | 36,467,975 | 68,019,656 |
Total equity and liabilities | 83,591,652 | 71,599,935 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises